BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22943386)

  • 1. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
    Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
    Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mammography screening in the county of Copenhagen. Results of the first three screening rounds].
    Tange UB; Hirsch FR; Jensen MB; Olsen AH; Blichert-Toft M; Rank FE; Vejborg IM; Mouridsen H; Lynge E
    Ugeskr Laeger; 2002 Feb; 164(8):1048-52. PubMed ID: 11894707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
    Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
    Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
    Matkowski R; Szynglarewicz B
    Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program.
    Hofvind S; Thoresen S; Tretli S
    Cancer; 2004 Oct; 101(7):1501-7. PubMed ID: 15378474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does educational level determine screening participation?
    von Euler-Chelpin M; Olsen AH; Njor S; Jensen A; Vejborg I; Schwartz W; Lynge E
    Eur J Cancer Prev; 2008 Jun; 17(3):273-8. PubMed ID: 18414200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative.
    Paquette D; Snider J; Bouchard F; Olivotto I; Bryant H; Decker K; Doyle G
    CMAJ; 2000 Oct; 163(9):1133-8. PubMed ID: 11079057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early outcome of mammography screening in Copenhagen 1991-99.
    Vejborg I; Olsen AH; Jensen MB; Rank F; Tange UB; Lynge E
    J Med Screen; 2002; 9(3):115-9. PubMed ID: 12370322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
    Castells X; Molins E; Macià F
    J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer incidence after the start of mammography screening in Denmark.
    Olsen AH; Jensen A; Njor SH; Villadsen E; Schwartz W; Vejborg I; Lynge E
    Br J Cancer; 2003 Feb; 88(3):362-5. PubMed ID: 12569377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.